Clinical Implementation of NGAL Testing to Improve Diagnostic Assessment of AKI Episodes in a Canadian Center.

Jean Maxime CôtéRoxanne AuthierIsabelle EthierJean-François CailhierWilliam Beaubien-SoulignyPatrick T MurrayPierre-Olivier HétuMarie-Claire Bélanger

Published in: Canadian journal of kidney health and disease (2022)

Neutrophil gelatinase-associated lipocalin testing can be successfully integrated as part of the diagnostic workup for AKI in clinical practice. The integration of tubular damage biomarkers to functional biomarkers can further improve the differential diagnostic assessment. However, the impact of such biomarkers on AKI management and associated outcomes still needs further validation.

Keyphrases

acute kidney injury
clinical practice
healthcare
primary care
oxidative stress
type diabetes
quality improvement
metabolic syndrome
insulin resistance